Matthew Posard

Mr. Matthew L.
Posard is an Executive Chairman at Stemson Therapeutics, LLC, a Chairman at Nautilus Biotechnology, Inc., a Chairman at Nautilus Subsidiary, Inc., a Chairman at DermTech, Inc., an Independent Director at Talis Biomedical Corp., a Partner at Explore DNA and an Independent Director at Halozyme Therapeutics, Inc. He is on the Board of Directors at Deepcell, Inc., Vizgen, Inc., Isolation Bio, Inc., Talis Biomedical Corp.
and Halozyme Therapeutics, Inc. Mr. Posard was previously employed as a President & Chief Commercial Officer by GenePeeks, Inc., a Chief Commercial Officer & Executive VP by TrovaGene, Inc., a Senior Vice President, GM-New & Emerging Markets by Illumina, Inc., a Regional Director-Sales by Alere San Diego, Inc., a Chairman by DermTech, Inc. /Old/, and a Senior Manager-Strategic Marketing by Gen-Probe, Inc. He also served on the board at Fabric Genomics, Inc. and SlipChip Corp.
He received his undergraduate degree from the University of California San Diego.